Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 6 ·1987-06-00 ·Pages 949-50

Shungu DL, Nalin DR, Gilman RH, Gadebusch HH, Cerami AT, Gill C, Weissberger B

Abstract

Twenty-one strains of Campylobacter pylori (Campylobacter pyloridis) were tested for susceptibility to norfloxacin and other agents by the serial agar dilution method. Ampicillin (MIC for 90% of isolates [MIC90], 0.016 micrograms/ml) and famotidine (MIC90, greater than 1,024 micrograms/ml) were, respectively, the most and the least active of the agents tested. Norfloxacin (MIC90, 1 microgram/ml) and imipenem (MIC90, 0.125 micrograms/ml) were substantially active against this organism.

MeSH Terms

Anti-Bacterial Agents/pharmacology Anti-Ulcer Agents/pharmacology Campylobacter/drug effects Microbial Sensitivity Tests Norfloxacin/pharmacology

Chemicals

Anti-Bacterial Agents Anti-Ulcer Agents Norfloxacin

Authors & Affiliations

7 authors, click to expand affiliations / ORCID

Shungu D L

Nalin D R

Gilman R H

Gadebusch H H

Cerami A T

Gill C

Weissberger B

References (10)

10 references, click to expand

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.
Lancet. 1984 Jun 16;1(8390):1311-5 PMID: 6145023
Antibiotic sensitivity of "Campylobacter pylori".
Eur J Clin Microbiol. 1984 Oct;3(5):444 PMID: 6499840
Pyloric Campylobacter infection and gastroduodenal disease.
Med J Aust. 1985 Apr 15;142(8):439-44 PMID: 3982346
Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content.
J Clin Microbiol. 1985 Dec;22(6):1007-10 PMID: 4066910
Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Drugs. 1986 Sep;32(3):197-221 PMID: 2875864
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
Antimicrob Agents Chemother. 1985 Dec;28(6):837-8 PMID: 2935076
Relation of Campylobacter pyloridis to gastritis and peptic ulcer.
J Infect Dis. 1986 Apr;153(4):664-9 PMID: 3950448
The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.
J Antimicrob Chemother. 1986 Mar;17(3):309-14 PMID: 3700291
Urea hydrolysis in patients with Campylobacter pyloridis infection.
Lancet. 1986 Apr 26;1(8487):965-6 PMID: 2871253
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1985 Dec;30(6):482-513 PMID: 3908074

Article Info

Journal

Antimicrobial agents and chemotherapy

Abbr.

Antimicrob Agents Chemother

ISSN

0066-4804

DOI

10.1128/AAC.31.6.949

Published

1987-06-00

Pages

949-50

Language

English

Region

United States

NLM ID

0315061

PMCID

PMC284219

Subset

External Links

PubMed source DOI: 10.1128/AAC.31.6.949 PMC Full Text View journal details

Analysis Services

Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.

Contact

WeChat Official Account